Mitral and Aortic Valve Prosthetic Endocarditis After Percutaneous Closure of Mitral Paravalvular Leak

A 67-year-old man presented to our hospital with massive mitral and aortic valve prosthetic endocarditis 2 months after transcatheter percutaneous closure of a mitral paravalvular leak with an Amplatzer duct occluder device (AGA Medical Corp, Plymouth MN). He underwent successful reoperation for val...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 2013-02, Vol.95 (2), p.e45-e46
Hauptverfasser: Malvindi, Pietro Giorgio, MD, Raffa, Giuseppe Maria, MD, Cappai, Antioco, MD, Barbone, Alessandro, MD, PhD, Basciu, Alessio, MD, Settepani, Fabrizio, MD, Citterio, Enrico, MD, Ornaghi, Diego, MD, Tarelli, Giuseppe, MD, Vitali, Ettore, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A 67-year-old man presented to our hospital with massive mitral and aortic valve prosthetic endocarditis 2 months after transcatheter percutaneous closure of a mitral paravalvular leak with an Amplatzer duct occluder device (AGA Medical Corp, Plymouth MN). He underwent successful reoperation for valve prosthesis replacement and reconstruction of the anterior fibrous trigone. Although transcatheter treatment of periprosthetic valve defects has been shown to be feasible, follow-up data are still limited. This procedure should be reserved only for patients who are not eligible for open surgical procedures and those with small periprosthetic defects.
ISSN:0003-4975
1552-6259
DOI:10.1016/j.athoracsur.2012.08.020